VBI Vaccines, Inc.
(Toronto Stock Exchange : VBIV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.69%72.610.9%$623.97m
CELGCelgene Corporation
0.27%128.001.1%$446.55m
AMGNAmgen Inc.
0.52%168.161.1%$420.65m
BIIBBiogen Inc.
0.51%283.221.2%$358.22m
REGNRegeneron Pharmaceuticals, Inc.
0.88%472.112.7%$324.67m
VRTXVertex Pharmaceuticals Incorporated
0.29%148.561.9%$265.37m
ALXNAlexion Pharmaceuticals, Inc.
1.46%135.351.9%$221.16m
ILMNIllumina, Inc.
0.08%189.463.5%$216.51m
SRPTSarepta Therapeutics, Inc.
0.19%36.7719.8%$138.71m
CLVSClovis Oncology, Inc.
0.33%72.2018.0%$129.63m
INCYIncyte Corporation
-1.03%119.942.6%$129.60m
TSROTESARO, Inc.
1.37%115.4314.7%$123.36m
KITEKite Pharma, Inc.
1.10%131.6116.1%$123.18m
AAgilent Technologies, Inc.
0.42%61.511.5%$119.53m
BMRNBioMarin Pharmaceutical Inc.
0.53%81.354.4%$109.16m

Company Profile

VBI Vaccines, Inc. is a biopharmaceutical company, which develops next generation vaccines to address unmet needs in infectious disease and immuno-oncology. Its products portfolio includes Sci-B-Vac, HBV, CMV Vaccine, GBM Immunotherapy and RSV Vaccine. The company is headquartered in Cambridge, MA.